Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Baxter
Johnson and Johnson
Argus Health
Cipla
Citi
Colorcon
Medtronic
Farmers Insurance
Merck

Generated: February 25, 2018

DrugPatentWatch Database Preview

VESPRIN Drug Profile

« Back to Dashboard

Which patents cover Vesprin, and when can generic versions of Vesprin launch?

Vesprin is a drug marketed by Apothecon and Bristol Myers Squibb and is included in three NDAs.

The generic ingredient in VESPRIN is triflupromazine. There are two drug master file entries for this compound. Additional details are available on the triflupromazine profile page.
Drug patent expirations by year for VESPRIN
Medical Subject Heading (MeSH) Categories for VESPRIN

US Patents and Regulatory Information for VESPRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon VESPRIN triflupromazine hydrochloride INJECTABLE;INJECTION 011325-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb VESPRIN triflupromazine hydrochloride TABLET;ORAL 011123-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apothecon VESPRIN triflupromazine SUSPENSION;ORAL 011491-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apothecon VESPRIN triflupromazine hydrochloride INJECTABLE;INJECTION 011325-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apothecon VESPRIN triflupromazine hydrochloride INJECTABLE;INJECTION 011325-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb VESPRIN triflupromazine hydrochloride TABLET;ORAL 011123-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb VESPRIN triflupromazine hydrochloride TABLET;ORAL 011123-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Deloitte
Fish and Richardson
Daiichi Sankyo
McKesson
Colorcon
Julphar
Express Scripts
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot